A Stamford clinical trial center is seeking participants in a new study that targets Alzheimer’s disease, a progressive, degenerative neurologic disease which currently affects 5.7 million Americans. New England Institute for Clinical Research is one of 40 medical and...
Oncologie, Inc. Announces Clinical Trial Collaboration With Merck to Evaluate Bavituximab in Combination With KEYTRUDA® (Pembrolizumab) in Advanced Gastric or Gastroesophageal Cancer Oncologie, Inc., a clinical-stage biopharmaceutical company developing innovative...
Results from single-ascending dose cohorts demonstrate that TERN-201 is generally safe and well tolerated and results in sustained inhibition of plasma SSAO activity The trial has now progressed to the multiple-ascending dose phase Terns Pharmaceuticals, Inc., a...
Company Expects to Report Top-Line Results from the Study by the end of October 2019 PolyPid Ltd., a clinical-stage biopharmaceutical company focused on developing and commercializing novel, locally administered therapies, announced today that it has completed patient...
– Study Being Conducted in Collaboration with Investigators at Arizona State University and the Mayo Clinic – Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing potentially best-in-class, oral therapies for the...
Biohit Oyj Stock Exchange Release August 9th 2019 at 15.30 pm local time (EET) In 2014, Biohit Oyj initiated two clinical trials for prevention of migraine-type headache attacks, testing the efficacy of Acetium® capsule. Because of a slow patient enrollment, the trial...
Email
Text